Spain Pricing & Access Leader – Value Strategy

ES06 (FCRS = ES006) Novartis Farmacéutica, S.A.; Barcelona; Presencial; EUR 140.000 - 210.000; Jornada completa

Descripción de la vacante

Novartis Farmacéutica, S.A. in Spain seeks a Head of Value & Pricing to define and execute pricing, value and contracting strategies across the portfolio, ensuring optimal value positioning with payers and authorities and maximizing patient access throughout the product lifecycle.

The role requires 8–10 years in Market Access/HEOR, proven leadership, and strong collaboration with cross-functional teams to translate clinical and economic evidence into strategic pricing decisions.

Formación

• 8–10 years’ experience in Market Access, Pricing, HEOR or related areas within pharma or consulting
• Proven experience leading and developing teams
• Experience in pricing strategy development and market analysis
• Preparation and support of pricing dossiers and business cases
• Project management in regulated environments
• Experience interacting with payers and health authorities

Responsabilidades

• Define pricing and value strategies for launches and in-market products
• Lead price negotiations and integrate clinical, economic and value evidence
• Manage pricing across product lifecycle and LoE impacts
• Design and implement payer agreement strategies and tenders
• Adapt international pricing guidance to the Spanish context
• Lead a pricing/contracting team and collaborate with Market Access, HEOR, Finance

Conocimientos

Pricing strategy

Market access

Team leadership

Negotiation

Cross-functional collaboration

Strategic thinking

Educación

Health economics, pharmacy, medicine degree

Descripción del empleo

Novartis Farmacéutica, S.A. in Spain seeks a Head of Value & Pricing to define and execute pricing, value and contracting strategies across the portfolio, ensuring optimal value positioning with payers and authorities and maximizing patient access throughout the product lifecycle.

The role requires 8–10 years in Market Access/HEOR, proven leadership, and strong collaboration with cross-functional teams to translate clinical and economic evidence into strategic pricing decisions.